期刊文献+

RP-HPLC法测定肿瘤患者血浆中紫杉醇浓度 被引量:3

Determination of Plasma Concentration of Paclitaxel in Tumor Patients by RP-HPLC
原文传递
导出
摘要 目的:建立以反相高效液相色谱法测定肿瘤患者血浆中紫杉醇浓度的方法。方法:采用有机相(乙酸乙酯)两步萃取,以反相高效色谱法测定,其中色谱柱为Tianhe Kromasil C18,流动相为乙腈-甲醇-水(40:25:40),流速为1.0mL·min^-1,检测波长为227nm,枉温为35℃。结果:血浆中紫杉醇的检测浓度在0.05~5.00mg·L^-1。范围内线性关系良好(r=0.9997);平均加样回收率为98.75%~100.44%,日内、日间RSD均〈5%(n=5)。应用本法测定了11例患者静脉滴注紫杉醇的经一时血药浓度,其符合药动学二室模型。结论:本法简便、准确、重现性好,可用于临床血药浓度的检测及药动学研究。 OBJECTIVE: To establish a RP - HPLC method to determinate the plasma concentration of paclitaxel in tumor patients. METHODS: Paclitaxel was extracted from plasma with organic phase(ethyl- acetate) by two- step extraction on Tianhe Kromasil C18 column(250 mm× 4.6 mm, 5 μm) with a mobile phase consisted of acetonitrile - methanol - water (40 : 25 : 40) at a flow rate of 1 mL·min^-1 1.The detective wavelength was set at 227 nm and the column temperature was main- tained at 35 ℃. RESULTS: The linear range of paclitaxel was 0.05--5.00 mg·L^-1 (r = 0.999 7) with average recovery rate at 98.75%- 100.44% .Both intra- day RSD and inter- day RSD were less than 5% (n = 5). The plasma concentration- time profile in 11 patients after iv infusion of paclitaxel was in line with a two- compartment model. CONCLUSION: This estab- lished method is simple, accurate, reproducible and applicable for clinical determination of blood drug concentration and pharmacokinetic studies.
出处 《中国药房》 CAS CSCD 北大核心 2009年第15期1179-1181,共3页 China Pharmacy
关键词 反相高效液相色谱法 紫杉醇 血药浓度 RP- HPLC Paclitaxel Blood drug concentration
  • 相关文献

参考文献6

二级参考文献36

  • 1王亚敏,石庭森,张艳红.抗癌新药紫杉醇的药剂学研究概况[J].中国医院药学杂志,1996,16(4):176-178. 被引量:5
  • 2张湘茹,孙燕.紫杉醇治疗非小细胞肺癌[J].中国新药杂志,1996,5(4):245-248. 被引量:31
  • 3黄红艳,杨云芬.静脉输注化疗药物对血管组织的损伤[J].实用护理杂志,1996,12(1):42-43. 被引量:122
  • 4徐莉,董锡裕.紫杉醇类抗癌药临床研究进展[J].国外医药(植物药分册),1996,11(1):5-7. 被引量:18
  • 5SaijoN,蔡洪川.日本抗癌新药临床前及临床研究进展[J].国外医学(药学分册),1997,24(3):163-165. 被引量:6
  • 6曾晓燕 鲁建春 张德操.精密过滤输液器用于肿瘤化疗的临床观察.护士进修杂志,2001,16(1):45-46.
  • 7Wani MC, Taylor HL, Wall ME, et al. Plant antitumor agents Ⅵ.The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia[J]. J Am Chem Soc, 1971,93(9) :2325 - 2327.
  • 8AL- Sarrf M. Treatment of locally advanced head and neck cancer[J]. Cancer Control,2002,9(5) :387 - 399.
  • 9Panvichian R,Orth K,Day ML,et al. Paclitaxel- associated multiminricmcleation is permitted by the inhibition of caspas sctivation:a potential early step in druy resistance[J]. Cancer Res, 1998,58(20) :4667.
  • 10Roussel E,Belanger MM,Couet J. G2/Mblockade by paclitaxel induces caveolin-1 expression in A549 lung cancer cells:caveolin- 1as a marker of cytotoxicity [ J ]. Anticancer Drugs, 2004,15 ( 10 ):961 - 967.

共引文献29

同被引文献42

  • 1周卫,翁帼英,陈文忠,庄翌,傅晓阳,程光.紫杉醇脂质体在大鼠体内的组织分布[J].中国药学杂志,2005,40(18):1402-1404. 被引量:54
  • 2陈永法,龚明涛,张钧寿,谢燕.紫杉醇冻干纳米乳在大鼠体内的药动学[J].中国天然药物,2005,3(6):370-372. 被引量:6
  • 3易村犍,凌晟荣,陈克明.C-Kit和PDGFR-α在卵巢上皮性癌组织中的表达及临床意义[J].中国实用妇科与产科杂志,2006,22(4):295-296. 被引量:5
  • 4李娜,孙国平,金涌,李俊.反向高效液相法测定血浆中多西紫杉醇的含量[J].安徽医科大学学报,2006,41(6):707-709. 被引量:9
  • 5Adel Tabchy, Vicente Valero, Tatiana Vidaurre, et al. Evaluation of a 30- Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cy- clophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer[J]. Clinical Cancer Research, 2010,16 : 5351-5361.
  • 6Henrik Green, Peter Sderkvist, Per Rosenberg, et al. Pharmaco- genetic Studies of Paclitaxel in the Treatment of Ovarian Cancer [J]. Basic Clinical Pharmacology Toxicology, 104, 130-137.
  • 7G Rajender and N. G. B. Narayanan. Sensitive and validated HPLC method for determination of paclitaxel in human serum [J], Indian Journal of Science and Technology, 2009,2 (5) z 52-54.
  • 8Ganta S,Devalapally H,Shahiwala A. A review of stimuli -responsive nanocarriers for drug and gene delivery. J ControlRelease, 2008,126 : 187 - 204.
  • 9Ruoslahti E,Bhatia SN, Sailor MJ. Targeting of drugs andnanoparticles to tumors. Cell Biol, 2010,188: 6759 - 6768.
  • 10WuJ,Liu Q , Lee RJ. A folate receptor - targeted liposomalformulation for paclitaxel. Int J of Pharm, 2006,316 : 148 -153.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部